AzTrials
AzTrials

Screening TestAPC-EndoNCT01320826

The Alberta Primary Care Endoscopy (APC-Endo) Study

An observational study of Screening Test and Endoscopy, run by University of Alberta at 13 sites in Canada.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

It is hypothesized that primary care colonoscopists are able to achieve benchmarks in colonoscopy quality including cecal intubation and adenoma detection rates and serious adverse event rates. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Screening Test, Endoscopy, Colon Disease
What is being tested?
colonoscopy
Type of treatment
Surgery or procedure
How many people
577 participants
Where
13 sitesCanada
Study dates
Mar 2010to Oct 2010
Phase
Observational
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Physician colonoscopists: All Albertan family physicians and general internists who perform colonoscopies will be invited to voluntarily participate in anonymized data collection pertaining to the quality of colonoscopies they perform over a two month period. All patients having a colonoscopy done by an APC-Endo physician endoscopist during the study period will be approached at the time of their endoscopy to consent to the post procedure telephone survey.

Who may be able to join

  • All patients having a colonoscopy done by an APC-Endo physician endoscopist during the study period will be approached at the time of their endoscopy to consent to the post procedure telephone.

Who cannot join

  • Patients under the age of 18 years old
  • Patients who will be unable to be contacted for the post procedure telephone survey. (e.g., moving out of the country in the following month)
  • Patients who are unable to understand or speak basic English
  • Patients who are cognitively impaired such that they were not able to complete the initial consent for their colonoscopy

Trial locations and contacts

13 sites in 1 country.

13 sites in 1 country

Canada13 sites
  • Barrhead Healthcare Centre

    Barrhead, Alberta, T7N 1M1

  • Bonnyville Healthcare Centre

    Bonnyville, Alberta, T9N 1M3

  • St. Mary's Hospital

    Camrose, Alberta, T4V 1Y5

  • Daysland Health Centre

    Daysland, Alberta, T08 1A0

  • Queen Elizabeth 2 Hospital

    Grande Prairie, Alberta, T8V 0N5

  • William J. Cadzow Health Centre

    Lac La Biche, Alberta, T0A 2C0

  • Sacred Heart Hospital

    McLennan, Alberta, T0H 2L0

  • Peace River Community Health Centre

    Peace River, Alberta, T8S 1T6

  • Pincher Creek Hospital

    Pincher Creek, Alberta, T0K 1W0

  • Ponoka Hospital and Care Centre

    Ponoka, Alberta, T4J 1P1

  • Sturgeon Community Hospital

    St. Albert, Alberta, T8N 6C4

  • Taber Hospital

    Taber, Alberta, T1G 1N9

  • Whitecourt Healthcare Centre

    Whitecourt, Alberta, T7S 1M8

Other trials in Canada

About this study

Official title: Prospective Study of the Quality of Colonoscopies Performed by Primary Care Endoscopists in Alberta, Canada

It is hypothesized that primary care colonoscopists are able to achieve benchmarks in colonoscopy quality including cecal intubation and adenoma detection rates and serious adverse event rates.

This prospective study is the first in depth analysis of the quality of colonoscopic procedures performed by primary care physicians at a provincial level in Canada.

In addition, the APC Endo study is the first to directly examine both the quality of colonoscopy and patient satisfaction in the same study.

Read the detailed description

Discrepant data exists about the quality of colonoscopies performed by family physicians and general internists. Currently in Canada, gastroenterologists and general surgeons perform 97% of the colonoscopies, but excessive wait times highlight a shortage of colonoscopists in Canada. This shortage will invariably worsen as our population ages and more Canadians become screened for colorectal cancer.

One method of improving this relative shortage of colonoscopists is through training primary care physicians in GI medicine and endoscopy. In order these physicians to be a legitimate option in the provision of colonoscopies; however, it must be shown that, as a group, they are able to meet benchmarks in colonoscopy competency.

This multi-centre observational study will be the first study to prospectively analyze colonoscopic examinations performed by primary care physicians at a provincial level. Using primarily cecal intubation rates and adenoma detection rates, along with other quality parameters, this study will compare the results of Alberta primary care physicians to standard benchmarks in colonoscopy competency.

Data will be collected using case report forms completed at the time of the colonoscopy, reviewing the patients' colonoscopy pathology results and a post procedure telephone survey to examine patient satisfaction rates.

If this study demonstrates that quality benchmarks are indeed met, then future training of primary care physicians in gastrointestinal medicine and endoscopy would be encouraged to help address current and future colonoscopist shortages.

Being tested
colonoscopy
Keywords
colonoscopy, primary care physicians, quality assurance
Medical subject headings
Colonic Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • colonoscopyProcedure or surgery

    Data pertaining to all colonoscopies performed by a APC-Endo study physician over a two month period will be collected.

Study groups in NCT01320826
Study groupRoleWhat they receive
Physician colonoscopistsAll primary care physicians (family physicians and general internists) who perform colonoscopies were approached to voluntarily participate in the APC-Endo study. All patients having a colonoscopy done by an APC-Endo study physician endoscopist were approached at the time of their endoscopy to consent to the post procedure telephone survey.
Receives: Procedure: colonoscopy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of Successful Cecal Intubations (Crude)

    The percentage of successful cecal intubations (crude) = (total # of colonoscopies performed where cecal intubation was achieved / total # of colonoscopies attempted) x 100

    Measured: At time of colonoscopy (DAY 1 of study)

  2. Percentage of Successful Cecal Intubations (Adjusted)

    The percentage of successful cecal intubations (adjusted) = total number of colonoscopies performed where cecal intubation was achieved / (total number of colonoscopies attempted -incomplete colonoscopies due to poor bowel preparation, colonic stricture, equipment failure or severe endoscopic colitis)

    Measured: At time of colonoscopy (DAY 1 of study)

  3. Adenoma Detection Ratio

    The adenoma detection ratio is the number of pathologically verified adenomas per number of colonoscopies performed. Adenoma detection ratio = total number of pathologically confirmed adenomas / number of colonoscopies attempted.

    Measured: When pathology from colonoscopy available (on average 2-3 weeks after procedure)

  4. Percentage of Males 50 Years and Older Undergoing First Time Colonoscopy With an Adenoma

    Percentage of patients with an adenoma = (number of patients who had at least one adenoma detected on colonoscopy / total number of colonoscopies attempted) x 100.

    For this specific outcome: we explored this outcome for males 50 years and older undergoing first time colonoscopy.

    Measured: When pathology from colonoscopy available (on average 2-3 weeks after procedure)

  5. Percentage of Females 50 Years and Older Undergoing First Time Colonoscopy With an Adenoma

    Percentage of patients with an adenoma = (number of patients who had at least one adenoma detected on colonoscopy / total number of colonoscopies attempted) x 100.

    For this specific outcome: we explored this outcome for females 50 years and older undergoing first time colonoscopy.

    Measured: [When pathology from colonoscopy available (on average 2-3 weeks after procedure)]

Secondary outcomes (7)
  1. Colonoscopy Complications: Bleeding, Perforation, Cardiopulmonary Complications Secondary to Conscious Sedation, and Death.

    Potential serious complications of colonoscopy include bleeding, perforation, cardiopulmonary complications secondary to conscious sedation and death.

    Potential serious complications will be determined from the case report form (physician reported) and at patient satisfaction phone survey (on average four weeks after colonoscopy).

    All potential serious complications of colonoscopy will be externally adjudicated.

    Measured: Within four (4) weeks of colonoscopy

  2. Colonoscopy Withdraw Time in Cases Where no Lesions Found

    Withdrawal time will be defined as the time from leaving the cecum until the colonoscope exits the anus. This will be calculated for cases in which no lesions were found.

    Measured: At time of colonoscopy (DAY 1 of study)

  3. Patient Comfort During Colonoscopy

    To determine the patients' comfort level during the colonoscopy, a five-item question used by the Joint Advisory Group on Gastrointestinal Endoscopy in the United Kingdom will be used.

    Patient discomfort on the 5 point scale:

    0 is no discomfort;

    1. is one or two episodes of discomfort, well tolerated;
    2. is more than two episodes of discomfort adequately tolerated;
    3. is significant discomfort experienced several times during the procedure;
    4. is extreme discomfort experienced frequency throughout the procedure.

    Minimum value = 0, maximum value = 4 with 4 being worse.

    Measured: At time of colonoscopy (DAY 1 of study)

  4. Patient Satisfaction With Endoscopy Wait Time

    Patient satisfaction with endoscopy wait time will be recorded using a 7 point Likert scale at the time of the patient phone survey. 7 is extremely satisfied and 1 is extremely dissatisfied

    minimum score = 1 maximum score = 7

    Measured: At patient satisfaction phone survey (on average 4 weeks after colonoscopy)

  5. Patient Satisfaction With Hospital Experience for Colonoscopy

    Patient satisfaction with their hospital experience during their colonoscopy will be recorded by using a 7 point Likert scale at the time of the patient satisfaction phone survey.

    7 = extremely satisfied

    1 = extremely dissatisfied

    Minimum score = 1 Maximum score = 7

    Measured: At patient satisfaction phone survey (on average 4 weeks after colonoscopy)

  6. Colonoscopy Procedure Time

    Colonoscopic procedural time will be defined as the time from the first insertion of the colonoscope until it is removed from the anus.

    Measured: At time of colonoscopy (DAY 1 of study)

  7. Percentage of Patients Referred to a Specialist.

    The percentage of patients who are anticipated to be referred to specialists, for the gastrointestinal complaint for which the colonoscopy was performed will be determined and the reason for referral will be tabulated. The referral percentage will be determined both from the time of colonoscopy (physician reported) and from the patient satisfaction phone survey (patient reported).

    Measured: Within four (4) weeks of colonoscopy

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Mar 2011 (estimated)
  2. Study startMar 2010
  3. Primary completionJun 2010
  4. Study completionOct 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
577 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01320826
Sponsor's protocol ID
2011-APCEndo-MK
Acronym
APC-Endo
Status last verified
Aug 2012
First submitted
3 Mar 2011
Last updated
15 Aug 2012
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

An observational study of Screening Test and Endoscopy, run by University of Alberta at 13 sites in Canada.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Aug 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 13 sites in Canada. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Aug 2012). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of Successful Cecal Intubations (Crude) (time frame: At time of colonoscopy (DAY 1 of study)). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in